Management of Regenics AS

Henrik Lund, Chief Executive Officer

Henrik Lund joined Regenics in 2014. Lund is an MD PhD from University of Oslo and received his post-doctoral training at UC San Francisco in lipidology. In 2005 – 2010 Lund served as VP of 
AstraZeneca's Marketing Company clinical development group. He has also served as CEO and Chairman of the Board of several Norwegian biotech/life science companies and is at present Chairman Board of Directors Oslo Cancer Cluster, NCE. Lund works as CEO for Regenics from his own consultancy company.

 

Christian Clemm, Chief Medical Officer

Christian Clemm joined Regenics in 2014. He is an MD from University of Oslo and has an MBA from Norwegian School of Management BI. He has more than 20 years of experience from the pharmaceutical industry, including positions as VP Healthcare Affairs in AstraZeneca Nordic Baltic and Regional Clinical Research Director in AstraZeneca Latin America. Previously, he has served as member of the board in several Norwegian life science companies, Oslo Cancer Cluster and Norwegian Bioindustry Association.

 

Gry Lønne Eriksson, Chief Scientific Officer

Gry Lønne Eriksson joined Regenics in 2012. Before joining Regenics, she worked as scientist and project manager at Affitech AS, Norway, developing therapeutic antibodies for cancer treatment. She has also worked as research scientist at Lund University, Sweden. Eriksson holds a PhD in tumour biology from the Faculty of Medicine at Lund University.

 

 

Dominika Andrys, Research and Formulation Scientist

Dominika Andrys joined Regenics in 2014. She graduated from West Pomeranian University of Technology, Szczecin with Master degree in Biotechnology. At the same University, currently, she continues her education on PhD studies. She holds education in Cosmetic Chemistry from Adam Mickiewicz University, Poznan. 

 

 

Mitchell Jones, Patent Attorney (US), JD PhD

Dr. Mitchell Jones is in charge of Regenics AS patents, trademarks and IP strategy since 2010. Dr. Jones is a founding shareholder of Casimir Jones S.C., Madison, Wisconsin, US. Dr. Jones recieved his, Juris Doctor, 1997 from Vanderbilt University and a Ph.D., Endocrinology-Reproductive Physiology, in 1994 from the University of Tennessee.  Dr. Jones has extensive experience in obtaining, litigating and licensing patents with special emphasis in patents in life science disciplines, and has obtained hundreds of patents worldwide for clients. Dr. Jones has experience in representing US and international companies, from start-ups to Fortune 500 companies, as well as leading United States universities.  Dr. Jones work for Regenics AS as a consultant.

 

Markus Heldrup, Production Manager

Markus Heldrup joined Regenics in 2014. He has a BSc degree from University of Oslo in Biochemistry. Heldrup is handling technical production of Regenics' ingredients at the Company's Research and production site at GE Healtcare site, Storo, Oslo, Norway. Heldrup is also supporting technical R&D on cell culture, collagen batch assays and varioius techniques. As production at Regenics is seasonal, Heldrup supports Regenics on a temporary basis while completing his MSc degree.

 

 Hege O'Wiidt, Research Technician

Hege O'Wiidt, support Regenics AS with temporary research technician work. Hege O'Wiidt is a certified animal nurse from NBU (Norwegian University of Life Sciences) and works at Dept. of Comparative Medicine, Oslo University Hospital.

 

 

 

Anne-Karine Haflan, CE marking/QA consultant

Anne-Karine Haflan is a senior independent consultant within quality assurance, regulatory affairs and project management for the medical device and pharmaceutical industry. Anne-Karine Haflan form Haflan Resources, signed up with Regenics in 2016 to support the CE marking submission of Vernex® and establish a robust quality management system. Haflan has previously worked as Project Manager, R&D Manager and Development Director at Axis-Shield PoC AS, Research Scientist at Dynal Biotech AS, Senter for Industriforskning and SI Institutt for Energiteknikk.

Contacts management:

Henrik Lund, CEO

mobile +47 90971219
henrik.lund@regenics.no

                     --

Christian Clemm, CMO

mobile +47 90795116
cc@regenics.no

                    --

Gry Lønne Eriksson, CSO

mobile +47 95892548
gl@regenics.no  

                    --

Dominika Andrys, 
Research
& Formulation Scientist

mobile +47 48679075
da@regenics.no

                    --

Mitchell Jones, Patent Attourney

mobile +1 608 6621277
jmjones@casimirjones.com

                    --

Markus Heldrup, CPO

mobile +47 40462843
mh@regenics.no

                    --

Hege O'Wiidt, Research Technician

mobile +47 99713681
how@regenics.no

                    --

Anne-Karine Haflan, CE marking, QA Assurance

mobile +47 97683900
nine@haflan.no

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.